Valuation: Amedica Corporation

Market Cap 6.76M 5.93M 5.52M 5.08M 9.52M 646M 9.69M 65.54M 25.65M 320M 25.38M 24.83M 1.11B P/E 2026 *
-0.73x
P/E 2027 * -1.09x
Enterprise Value 6.76M 5.93M 5.52M 5.08M 9.52M 646M 9.69M 65.54M 25.65M 320M 25.38M 24.83M 1.11B EV / Sales 2026 *
2.93x
EV / Sales 2027 * 1.28x
Free-Float
65.08%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 6.69M
+2.93%+10.18%-13.50%+22.47% 129B
+3.27%+6.71%+2.48%+0.97% 13.01B
-0.38%-1.15%+59.43%+98.21% 8.92B
+1.19%+5.60%-44.17%-69.43% 4.65B
+0.75%-.--%-.--%+16.65% 3.63B
-2.12%-1.89%-1.61%+35.57% 2.68B
-1.19%+0.88%-26.36%-34.82% 1.63B
+4.50%+8.93%+8.05%-53.34% 1.63B
+0.38%-1.97%-18.67%-25.95% 1.61B
Average +0.14%+1.55%-3.82%-1.07% 18.54B
Weighted average by Cap. +2.55%+4.65%-8.69%+20.60%

Financials

2026 *2027 *
Net sales 2.3M 2.02M 1.88M 1.73M 3.25M 220M 3.3M 22.33M 8.74M 109M 8.65M 8.46M 377M 5.27M 4.62M 4.3M 3.96M 7.42M 503M 7.55M 51.07M 19.99M 250M 19.77M 19.35M 862M
Net income -12.38M -10.86M -10.12M -9.3M -17.44M -1.18B -17.74M -120M -46.98M -586M -46.47M -45.47M -2.03B -11.38M -9.98M -9.3M -8.55M -16.03M -1.09B -16.31M -110M -43.17M -539M -42.71M -41.79M -1.86B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-